Answers are grounded in this paper and cite their sources.
Current research evidence suggests that tricyclic antidepressants and selective serotonin reuptake inhibitors are as effective in human immunodeficiency virus-seropositive depressed patients as they are in depressed patients without physical illness. There is preliminary evidence that selective serotonin reuptake inhibitors are better tolerated than tricyclic antidepressants. Psychostimulants may be useful in acquired immunedeficiency syndrome patients with depressed mood and lethargy. Interpersonal psychotherapy may be the most effective nonpharmacological approach in human immunodeficiency virus-seropositive individuals with depressive symptoms.
No takes yet. Share an insight, caveat, or question.
Maj et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: